Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, September 6 '25)

Image
By G.M.

 


    Am J Obstet Gynecol

  1. ROSSEN LM, Hoyert DL, Horon I, Branum AM, et al
    Trends in Maternal Mortality Rates by State, United States, 2018-2023.
    Am J Obstet Gynecol. 2025 Aug 28:S0002-9378(25)00585.
    PubMed         Abstract available


    Antiviral Res

  2. BI W, Zhu T, Xu Y, Chen Y, et al
    An engineered chimeric ACE2-HR2 peptide exhibits potent and broad-spectrum activity against SARS-CoV-2 variants.
    Antiviral Res. 2025;242:106265.
    PubMed         Abstract available

  3. ICHIKAWA T, Tamura T, Nao N, Suzuki H, et al
    Characterization of remdesivir resistance mutations in COVID-19 patients with various immunosuppressive diseases.
    Antiviral Res. 2025;242:106264.
    PubMed         Abstract available

  4. TASHIMA R, Kuroda T, Nobori H, Miyagawa S, et al
    Ensitrelvir suppresses prolonged olfactory abnormalities derived from SARS-CoV-2 infection in hamsters.
    Antiviral Res. 2025 Sep 2:106270. doi: 10.1016/j.antiviral.2025.106270.
    PubMed         Abstract available

  5. ZHU C, Wang Z, Pan Z, Mai X, et al
    DMBT1 promotes SARS-CoV-2 infection and its SRCR-derived peptide inhibits SARS-CoV-2 infection.
    Antiviral Res. 2025 Sep 3:106269. doi: 10.1016/j.antiviral.2025.106269.
    PubMed         Abstract available


    BMJ

  6. DEWIDAR O, Shamseer L, Melendez-Torres GJ, Akl EA, et al
    Improving the reporting on health equity in observational research (STROBE-Equity): extension checklist and elaboration.
    BMJ. 2025;390:e083882.
    PubMed         Abstract available


    Clin Infect Dis

  7. DRAGHIA-AKLI R, Hill NM, Altevogt B, Bradley K, et al
    The Indispensable Value of Small-Molecule Antivirals in Epidemic and Pandemic Preparedness.
    Clin Infect Dis. 2025 Sep 1:ciaf476. doi: 10.1093.
    PubMed         Abstract available

  8. CHAICHANA U, Man KKC, Ju C, Makaronidis J, et al
    Effect of Metformin on the Risk of Post-coronavirus Disease 2019 Condition Among Individuals With Overweight or Obese: A Population-based Retrospective Cohort Study.
    Clin Infect Dis. 2025 Sep 1:ciaf429. doi: 10.1093.
    PubMed         Abstract available


    Int J Infect Dis

  9. FERNANDEZ-DE-LAS-PENAS C, Ruiz-Ruigomez M, Esparcia-Pinedo L, Colom-Fernandez B, et al
    Classical Pathway Persistent Complement Activation is Associated with Specific Symptoms in Individuals with Post-COVID-19 Condition: A Case-Control Study.
    Int J Infect Dis. 2025 Aug 28:108032. doi: 10.1016/j.ijid.2025.108032.
    PubMed         Abstract available

  10. SHANG L, Perniciaro S, Weinberger DM
    Changes in pneumococcal deaths in the United States following the COVID-19 pandemic.
    Int J Infect Dis. 2025 Aug 29:108020. doi: 10.1016/j.ijid.2025.108020.
    PubMed         Abstract available

  11. SIMONSEN L, Pedersen RK, Andreasen V, Krause TG, et al
    A Disease Suppression Strategy in Action: The Impact of Non-Pharmaceutical interventions in the COVID-19 pandemic in Denmark.
    Int J Infect Dis. 2025 Sep 2:108039. doi: 10.1016/j.ijid.2025.108039.
    PubMed         Abstract available

  12. SAGHAUG CS, Markussen DL, Knoop ST, Holvik BC, et al
    Diagnostic Accuracy of a Host Response Test in Suspected Community-Acquired Pneumonia During the COVID-19 Era.
    Int J Infect Dis. 2025 Sep 2:108045. doi: 10.1016/j.ijid.2025.108045.
    PubMed         Abstract available


    J Infect

  13. STANLEY J, Arnold D, Hamilton F
    Genetic evidence supports trialling IL-6 inhibition in influenza.
    J Infect. 2025 Aug 31:106606. doi: 10.1016/j.jinf.2025.106606.
    PubMed        

  14. PRITCHARD E, Vihta KD, Lipworth S, Pouwels KB, et al
    An Electronic Health Record-Wide Association Study to identify populations at increased risk of E. coli bloodstream infections.
    J Infect. 2025 Sep 3:106612. doi: 10.1016/j.jinf.2025.106612.
    PubMed         Abstract available


    J Med Virol

  15. MAK WA, Wapperom D, Redel AL, Koeleman JGM, et al
    Seasonal Coronavirus-Induced Immunological Imprinting and Previous Herpesvirus Infections in Patients With Long COVID.
    J Med Virol. 2025;97:e70582.
    PubMed         Abstract available


  16. Correction to "Modeling Antibody Kinetics Post-mRNA Booster Vaccination and Protection Durations Against SARS-CoV-2 Infection".
    J Med Virol. 2025;97:e70590.
    PubMed        

  17. HOSSEINI ST, Mahmanzar M, Rahimian K, Bayat S, et al
    Spatial Transcriptomics and Single Cell-RNASeq Reveals Cellular Heterogeneity of SARS-CoV-2 in Lung Tissues and Global Mutational Patterns in COVID-19 Patients.
    J Med Virol. 2025;97:e70586.
    PubMed         Abstract available


    J Virol

  18. GRACIE NP, Aggarwal A, Luo R, Spicer M, et al
    An RGD motif on SARS-CoV-2 Spike induces TGF-beta signaling and downregulates interferon.
    J Virol. 2025 Sep 4:e0043525. doi: 10.1128/jvi.00435.
    PubMed         Abstract available

  19. JOSEPH R, Marais G, Iranzadeh I, Alisoltani A, et al
    Intra-host SARS-CoV-2 diversity in immunocompromised people living with HIV provides insight into the evolutionary trajectory of SARS-CoV-2.
    J Virol. 2025 Sep 5:e0078025. doi: 10.1128/jvi.00780.
    PubMed         Abstract available


    JAMA

  20. SURIE D, Self WH, Yuengling KA, Lauring AS, et al
    RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons.
    JAMA. 2025 Aug 30:e2515896. doi: 10.1001/jama.2025.15896.
    PubMed         Abstract available

  21. ANDERER S
    Breaking From CDC, ACOG Continues Recommending COVID-19 Vaccine During Pregnancy.
    JAMA. 2025 Sep 5. doi: 10.1001/jama.2025.16943.
    PubMed        


    Lancet

  22. CHANG AY, Bolongaita S, Cao B, Castro MC, et al
    Epidemiological and demographic trends and projections in global health from 1970 to 2050: a descriptive analysis from the third Lancet Commission on Investing in Health, Global Health 2050.
    Lancet. 2025;406:940-949.
    PubMed         Abstract available


    Lancet Infect Dis

  23. VON LILIENFELD-TOAL M, Khawaja F, Compagno F, Robin C, et al
    Community-acquired respiratory virus infections in patients with haematological malignancies or undergoing haematopoietic cell transplantation: updated recommendations from the 10th European Conference on Infections in Leukaemia.
    Lancet Infect Dis. 2025 Aug 27:S1473-3099(25)00365.
    PubMed         Abstract available

  24. FOCOSI D, Maggi F
    Reassessing sotrovimab's role in COVID-19: insights and implications.
    Lancet Infect Dis. 2025 Aug 28:S1473-3099(25)00410.
    PubMed        


  25. Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet Infect Dis. 2025 Aug 28:S1473-3099(25)00361.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »